Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · PARKHOSPS

PARKHOSPS

HealthcareHealthcare Services₹10282 cr market cap
₹237.43 ▼ -0.26% today As of 19 Nov 2026
52-week low ₹143.9252-week high ₹299.30

-20.5% from the 52-week high · +65.4% above the low

Park Medi World Ltd is a healthcare services provider engaged in operating multi-specialty hospitals. The company delivers tertiary and quaternary medical care across a wide range of clinical disciplines. Its services include diagnostics, inpatient care, surgical procedures, and specialized treatments. Park Medi World focuses on integrated healthcare delivery supported by medical infrastructure and skilled professionals. The business model combines patient care with institutional healthcare services.

The short version. Return on equity was 12.8% in Mar 2026. Promoter holding was 82.9% in Sep 2026, up 0.01 points over 5 quarters.

1 · The price

How has the stock traded?

PARKHOSPS trades 20.5% below its 52-week high and 65.4% above its 52-week low.

Change over period: —

1M+4.5%
3M-12.0%
6M-7.1%
1Y—

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025
Revenue511476460410
Net profit52837151
Net margin %10.217.315.412.4
EPS (₹)1.211.911.641.18

Annual

FY2026
Revenue1679
Net profit258
Net margin %15.4
EPS (₹)5.98

3 · The quality

How well does it turn capital into profit?

Return on equity was 12.8% in Mar 2026; debt to equity is 0.11.

Profitability · 1 years

Returns and margins

Mar 2026
Return on equity %12.8
Return on capital %18.1
EBITDA margin %27.8
Net margin %15.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.11
Interest cover7.0x
Current ratio2.06
P/E ratio36.9

4 · The owners

Who holds it, and are they adding?

Promoter holding82.9%

Up 0.01 pts over 5 quarters.

Foreign institutions0.88%

Down 1.09 pts over 5 quarters.

Domestic institutions8.24%

Up 1.58 pts over 5 quarters.

Mutual fund schemes24

+5 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter82.8982.8982.8982.8982.9+0.01
FII1.971.280.860.820.88-1.09
DII6.668.789.258.958.24+1.58
Public8.487.056.997.337.99-0.49

Mutual fund holdings · Oct 2026

24 schemes hold this stock

19 the month before.

  • Taurus Flexi Cap Fund3.15% of NAV
  • Taurus Elss Tax Saver Fund2.73% of NAV
  • Kotak Consumption Fund2.67% of NAV
  • Kotak Healthcare Fund2.42% of NAV
  • Kotak Special Opportunities Fund1.91% of NAV
  • Kotak Contra Fund1.45% of NAV
  • ITI ELSS Tax Saver Fund1.44% of NAV
  • Kotak Multi Asset Allocation Fund1.34% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for PARKHOSPS are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about PARKHOSPS

What is the PARKHOSPS share price?

PARKHOSPS (PARKHOSPS) last closed at ₹237.43, down 0.26% on the day. Its 52-week range is ₹143.92 to ₹299.30.

What is the market cap of PARKHOSPS?

PARKHOSPS has a market capitalisation of about ₹10,282 crore. Its price-to-earnings ratio is 36.9.

How are PARKHOSPS's latest results?

Return on equity was 12.8% in Mar 2026. Promoter holding was 82.9% in Sep 2026, up 0.01 points over 5 quarters.

Who owns PARKHOSPS?

As of Sep 2026, shareholding was: Promoter 82.9%, FII 0.88%, DII 8.24%, Public 7.99%.

How many mutual funds hold PARKHOSPS?

24 mutual fund schemes held PARKHOSPS in October 2026. That compares with 19 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.